Pfizer withdraws EU application for Macugen label extension

Pfizer Inc. (NYSE:PFE) withdrew an application to extend the label for Macugen pegaptanib in Europe to include visual impairment due to diabetic macular edema. According to EMA, Pfizer made the decisi...